Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
Ye Jin Ahn, Hyung Bin Hwang, Sung Kun Chung
Korean J Ophthalmol. 2014;28(2):177-180.   Published online 2014 Mar 14     DOI: https://doi.org/10.3341/kjo.2014.28.2.177
Citations to this article as recorded by Crossref logo
Therapeutic Strategies for Corneal Wound Angiogenesis
Sumana R. Chintalapudi
Current Pathobiology Reports.2020; 8(1): 15.     CrossRef
Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review
Archana A. Gupta, Danny A. Mammo, Michael A. Page
Graefe's Archive for Clinical and Experimental Ophthalmology.2020; 258(1): 167.     CrossRef
Anti-VEGF Treatment in Corneal Diseases
Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia, Massimo Busin
Current Drug Targets.2020; 21(12): 1159.     CrossRef
Current and emerging therapies for corneal neovascularization
Danial Roshandel, Medi Eslani, Alireza Baradaran-Rafii, Albert Y. Cheung, Khaliq Kurji, Sayena Jabbehdari, Alejandra Maiz, Setareh Jalali, Ali R. Djalilian, Edward J. Holland
The Ocular Surface.2018; 16(4): 398.     CrossRef
Therapeutic Potential of Ranibizumab in Corneal Neovascularization
Marianne L. Shahsuvaryan
Trends in Pharmacological Sciences.2017; 38(8): 667.     CrossRef
Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
Belghmaidi Sarah, Hajji Ibtissam, Baali Mohammed, Soummane Hasna, Moutaouakil Abdeljalil
Journal of Ophthalmology.2016; 2016: 1.     CrossRef